159 related articles for article (PubMed ID: 36631713)
1. Differential prognostic significance of sarcopenia in metastatic esophageal squamous and adenocarcinoma.
Zeuge U; Fares AF; Soriano J; Hueniken K; Bajwa J; Wang W; Schmid S; Rudolph-Naiberg S; Brown MC; Yeung J; Chen EX; Jang RW; Xu W; Elimova E; Liu G; Rozenberg D; McInnis MC
Esophagus; 2023 Jul; 20(3):557-566. PubMed ID: 36631713
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of nutritional markers in metastatic gastric and esophageal adenocarcinoma.
Ma LX; Taylor K; Espin-Garcia O; Anconina R; Suzuki C; Allen MJ; Honorio M; Bach Y; Allison F; Chen EX; Brar S; Swallow CJ; Yeung J; Darling GE; Wong R; Kalimuthu SN; Jang RW; Veit-Haibach P; Elimova E
Cancer Med; 2021 Jan; 10(1):199-207. PubMed ID: 33295697
[TBL] [Abstract][Full Text] [Related]
3. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
5. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
[TBL] [Abstract][Full Text] [Related]
7. Sarcopenia as an independent prognostic factor in patients with metastatic colorectal cancer: A retrospective evaluation.
da Cunha LP; Silveira MN; Mendes MCS; Costa FO; Macedo LT; de Siqueira NS; Carvalheira JBC
Clin Nutr ESPEN; 2019 Aug; 32():107-112. PubMed ID: 31221274
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
[TBL] [Abstract][Full Text] [Related]
9. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
[TBL] [Abstract][Full Text] [Related]
10. Low Body Mass Index Is an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.
Minami S; Ihara S; Nishimatsu K; Komuta K
World J Oncol; 2019 Dec; 10(6):187-198. PubMed ID: 31921375
[TBL] [Abstract][Full Text] [Related]
11. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
12. Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.
Paireder M; Asari R; Kristo I; Rieder E; Tamandl D; Ba-Ssalamah A; Schoppmann SF
Eur J Surg Oncol; 2017 Feb; 43(2):478-484. PubMed ID: 28024944
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia is associated with prognosis in patients with esophageal squamous cell cancer after radiotherapy or chemoradiotherapy.
Qian J; Si Y; Zhou K; Tian Y; Guo Q; Zhao K; Yu J
BMC Gastroenterol; 2022 Apr; 22(1):211. PubMed ID: 35501704
[TBL] [Abstract][Full Text] [Related]
14. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
15. Impact of Body Mass Index and Sarcopenia on Short- and Long-Term Outcomes After Esophageal Cancer Surgery: An Observational Study.
Kim GW; Nam JS; Abidin MFBZ; Kim SO; Chin JH; Lee EH; Choi IC
Ann Surg Oncol; 2022 Oct; 29(11):6871-6881. PubMed ID: 35622181
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
18. Myosteatosis in a systemic inflammation-dependent manner predicts favorable survival outcomes in locally advanced esophageal cancer.
Gabiatti CTB; Martins MCL; Miyazaki DL; Silva LP; Lascala F; Macedo LT; Mendes MCS; Carvalheira JBC
Cancer Med; 2019 Nov; 8(16):6967-6976. PubMed ID: 31571402
[TBL] [Abstract][Full Text] [Related]
19. Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
Khan AI; Psutka SP; Patil DH; Hong G; Williams MA; Bilen MA; Sekhar A; Kissick HT; Narayan VM; Joshi SS; Ogan K; Master VA
Cancer; 2022 Jun; 128(11):2073-2084. PubMed ID: 35285950
[TBL] [Abstract][Full Text] [Related]
20. Influence of sarcopenia, clinical data, and 2-[
Anconina R; Ortega C; Metser U; Liu ZA; Suzuki C; McInnis M; Darling GE; Wong R; Taylor K; Yeung J; Chen EX; Swallow CJ; Bajwa J; Jang RW; Elimova E; Veit-Haibach P
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1012-1020. PubMed ID: 34491404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
